openPR Logo
Press release

Movement Disorder Sales Likely to Bolster with Rise in Applications during Forecast Period, details Fact.MR study | Key Players - Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation , Mayo Clinic

07-10-2019 01:07 PM CET | Health & Medicine

Press release from: Fact.MR

Movement Disorder Sales Likely to Bolster with Rise

Prevalence of the mental disorders has continued to remain high among the old aged population globally. Neurological diseases such as Huntington’s disease, Parkinson’s disease and multiple symptom atrophy (MSA) continues to propel demand for management of the movement disorders. Lack of production of brain chemical dopamine by the nerve cells in the brain leads to uncoordinated movements and mental disorders that impact the everyday activities of the persons. According to Fact.MR, the global movement disorder market is expected to represent a value of over US$ 1,000 Mn by the end of 2026.

Request a sample of this premium report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=329

Inability to generate movements affects the functioning of nerves, brain and the spinal cord adversely. Neurological disorders has led to surge in diseases such as trauma, convulsive diseases, cerebrovascular diseases, brain tumors and degenerative diseases. Growing prevalence of such mental disorders impact the cognitive abilities and lead to increasing prevalence of insomnia, depression, swallowing, inability to chew and speaking. Surge in awareness attributed to increasing prevalence of the neurological diseases is expected to impact growth of the global movement disorders market positively.

FDA Approval to Boost Sales of Medications

Medications and treatments approved by FDA is also expected to impact growth of the global movement disorder market. Xadago (safinamide) tablets and Ingrezza capsules are two drugs that have recently cleared the FDA pipeline. Ingrezza capsules have recently received approval for treatment of dyskinesia and Xadago (safinamide) tablets have received approval of Parkinson’s disease. In addition, the FDA has also approved implantation of brain to reduce the tremor symptoms. These factors are further expected to boost growth of the global movement disorders market.

Advanced Features to Impact Growth of the Global Market

In order to gain a competitive edge, various companies operating in the global movement disorder market are focusing on product innovation and developments. Manufacturers are mainly concentrating on incorporating advanced technology in the medical devices for faster recovery and improved results. Equipped with the advanced features such as sensors, 360-degree stabilizing solutions and cloud technology. Parkinson’s spoon equipped with advanced technological features enable the end users to retrieve and store information regarding the status of the unwanted tremors and generates the algorithm of tremor patterns for optimal stabilization. Moreover, the manufacturers operating in the global market are offering the electronic stabilizing handle, which comprises everyday spoon, spork, soup spoon and a fork. Bound to these factors, the global movement disorders market is expected to witness significant growth during the forecast period.

On the other hand, various factors continue to impact growth of the global movement disorders market negatively. Lack of investment in research and development will continue to inhibit growth of the global movement disorder market. In addition, slow approval of the medications developed is further likely to impact growth of the global market negatively. Moreover, poor method of therapeutics conducted continues to pose significant challenges towards growth of the global market.

Browse full report along with TOC and List of Figures at: https://www.factmr.com/report/329/movement-disorder-market

Parkinson ’s disease to Represent a Leading Segment

Growing need for medical devices with the uninterrupted functioning for treatment of the neurological disorders has led to an upsurge in adoption of rechargeable deep brain stimulator devices. On the basis of product type, the rechargeable deep brain stimulator devices segment is expected to generate significant revenues, accounting for a value of over US$ 500 Mn by the end of 2026. However, the non-rechargeable deep brain stimulator devices product type segment is expected to register the highest CAGR during the forecast period.

Based on end user, the hospitals segment is expected to represent the highest revenue growth, recording a value of less than US$ 100 Mn by the end of 2017. On the other hand, the clinics end user segment is expected to register a robust through 2026.

By application, the Parkinson’s disease segment is expected to represent a significant revenue growth, accounting for a value of over US$ 400 Mn by the end of 2026. In contrary to this, the dystonia application segment is expected to register a healthy CAGR throughout the forecast period.

Competition Tracking

Leading market players operating in the global movement disorder market include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation and Mayo Clinic.

Ask to our Industry Expert @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=329

Contact Us            
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
Read Industry News at - https://www.industrynewsanalysis.com/

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Movement Disorder Sales Likely to Bolster with Rise in Applications during Forecast Period, details Fact.MR study | Key Players - Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation , Mayo Clinic here

News-ID: 1800772 • Views: 2266

More Releases from Fact.MR

Trailer Canopy Market: North America to Have an Upper Hand Over Europe, Fact.MR …
Domestic Players gain from Consumer Proximity On-demand customizations and vehicle innovations largely influence the trailer canopy market and contribute in its market growth. Trailer canopies are used for many purposes and their purpose has grown beyond providing shade. Major stake holders in the market have introduced many solutions in accordance with customer need. Customized trailer canopies attract customer attention. Metal based trailer canopies are the other type that are highly demanded.
Ammonium Chloride Market to Witness Steady Growth | Haohua Junhua Group Co Ltd, …
Ammonium chloride is extensively used in many applications of which its application as fertilizers is highly sought after. Paddy cultivation prominently uses ammonium chloride fertilizers. Increase in cultivation of rice across the globe intensifies demand for Ammonium Chloride for its nitrogenous content. Fact.MR report predicts that demand for Ammonium Chloride of pharma grade will increase in future owing to the growing demand for cold and cough medicines that contain it.
Dredging Market Investment Research Report 2021 to 2031 | Jan De Nul Group, Pe …
The new report on the Keyword market provides estimations of the size of the global market and share and size of key regional markets during the historical period of 2016 – 2020. According to Fact.MR, the global dredging market is forecast to be valued at US$ 21 Bn in 2031. Rise in demand from the oil & gas industry too is expected to propel demand for dredging as time goes
Data Center Market to Grow US$ 178,000 Mn Revenues by 2028 | IBM Corporation, …
Fact.MR has adopted multi-disciplinary approach to shed light on the evolution of the global Data Center market during the historical period of 2013 – 2017. A recently developed Fact.MR study foresees the data center market to record a splendid 12.0% CAGR over the period of forecast, 2018 to 2028. Installation & construction services will continue to account for bulk share of the data center market, albeit growing at a slightly

All 5 Releases


More Releases for Parkinson’s

Parkinson’s Disease Therapeutic Market- Trends, Outlook 2025
Parkinson’s disease (PD) is a chronic disorder characterized by the malfunctioning and death of vital nerve cells in the brain, and can be characterized by tremor, dementia, and depression. Parkinson’s disease progression leads to uncontrolled body movement of the patient. There is no cure presently for parkinson’s disease only treatments options such as medication and surgery to manage the symptoms are available. Parkinson’s disease mainly affects people over 50 and
Parkinson’s disease Therapeutics Parkinson’s disease Therapeutics Market to …
This report studies the global Parkinson's Disease Therapeutics market, analyzes and researches the Parkinson's Disease Therapeutics development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like GSK Novartis Boehringer Ingelheim Teva Pharmaceutical Abbvie ….. Ask for sample copy @ https://www.researchtrades.com/request-sample/1199125 Market segment by Regions/Countries, this report covers United States EU Japan China India Southeast Asia Market segment by Type, Parkinson's Disease Therapeutics can be split into Medications Therapeutics Medical Devices Therapeutics Buy
US Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in the United States in recent years and it most likely to continue rising in the near future. It has been estimated that at least 500,000 people in the United States currently have been diagnosed with this disease. The society pays a significant amount towards treating this disease in the country. It is estimated that the total cost to the nation exceeds
Europe Parkinson’s Disease Drug Pipeline Analysis
Parkinson’s disease incidence has been on a rise in Europe in recent years and it most likely to continue rising in the near future. It has been estimated that currently, more than 1 million in Europe are affected by Parkinson’s disease. This figure is most likely to double by 2030. Among the most common neurodegenerative disease (after Alzheimer’s disease), Parkinson’s is the second most common and it is expected that
Parkinson’s Disease - Heat Map and Analysis
ReportsWorldwide has announced the addition of a new report title Parkinson’s Disease - Heat Map and Analysis to its growing collection of premium market research reports. Parkinson’s disease (PD) is a chronic and progressive neurodegenerative disorder characterized by the progressive loss of muscular control, leading to resting tremor, rigidity, akinesia and postural reflex impairment. PD is an age-related disorder; symptoms typically begin to first appear in patients in their mid-sixties,
New Education Options for Parkinson’s Caregivers
(4/30/2012- Gilbert, Ariz.) When a loved one is diagnosed with Parkinson’s Disease (PD), it becomes clear that Parkinson’s is a life- changing experience for the entire family — particularly for the primary care provider, who is most often a spouse, child or parent. Family caregivers may not think of themselves as a care providers or recognize their new caregiving tasks. As family members begin helping with doctor visits, taking over financial